CompletedNCT02060084
Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm
Medication studyChinaEating disorders
Understand this study
- Listed locations
- KunshanSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2014
- Recruitment status
- Completed
- Enrollment listed in the registry
- 60
- Sponsor
- Wang Hua
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- China
- Age range
- Up to 24 Hours
- Official registry ID
- NCT02060084
- Official title
Show the full official title
Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Kunshan
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Wang Hua.
Did this study involve medication?
Yes. The study involved medication, including a control group and a probiotic-supplemented group.
